Lisdexamfetamine Dimesylate
Brand name: Lisdexamfetamine Dimesylate
Rank #314 of 500 drugs by total cost
$35.7M
Total Cost
88,692
Total Claims
$35.7M
Total Cost
4,154
Prescribers
$403
Cost per Claim
2,334
Beneficiaries
91,717
30-Day Fills
$8,594
Avg Cost/Provider
21
Avg Claims/Provider
About Lisdexamfetamine Dimesylate
Lisdexamfetamine Dimesylate (sold as Lisdexamfetamine Dimesylate) was prescribed 88,692 times by 4,154 Medicare Part D providers in 2023, costing the program $35.7M. At $403 per claim, this is a moderately priced medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 311 | Naloxegol Oxalate (Movantik) | $36.1M | 85,094 |
| 312 | Valacyclovir Hcl (Valacyclovir) | $35.9M | 827,731 |
| 313 | Sodium Oxybate (Xyrem) | $35.8M | 2,160 |
| 314 | Lisdexamfetamine Dimesylate (Lisdexamfetamine Dimesylate) | $35.7M | 88,692 |
| 315 | Ketoconazole (Ketoconazole) | $35.4M | 1,346,512 |
| 316 | Oxcarbazepine (Oxcarbazepine) | $35.3M | 430,248 |
| 317 | Trametinib Dimethyl Sulfoxide (Mekinist) | $35.0M | 2,448 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology